Interventional pain management is the use of minimally invasive procedures to treat chronic pain. Chronic pain can significantly impact a patient's quality of life, limit their mobility and ability to perform daily activities, and ultimately impact their mental, emotional, and financial well-being. The goal of this type of treatment is to help a patient achieve the level of function and quality of life they desire. The procedures used in interventional medicine are highly effective and offer the most advanced options for treating chronic pain.
Interventional pain management techniques include discography, a procedure that involves injecting a dye into the disc that is then analyzed with an x-ray or CT scan. Other procedures include pulsed radiofrequency neurotomy, which disables spinal nerves to stop pain signals from reaching the brain. The procedure can also be performed as an alternative to surgery. Depending on the individual's symptoms and condition, interventional pain management can result in functionally reduced pain and a pain-free life. However, not all patients will experience the same results.
Read More:
Click here for Interventional Pain Management Market Report:
https://www.coherentmarketinsights.com/market-insight/interventional-pain-management-market-2273
The global fluoroscopy equipment market is projected to reach USD 7.1 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 4.4%.The major factors driving the growth of the fluoroscopy equipment are the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market in 2018.
The large share of this segment can be attributed to the increasing use of fluoroscopic imaging for diagnosis and interventional procedures and technological advancements in fixed C-arms.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341Surgical applications segment to grow at the highest CAGR in the fluoroscopy equipment market during the forecast period On the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.
The diagnostic applications market is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology), while the surgical applications market covers the market for C-arms in orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications.North America will continue to dominate the fluoroscopy equipment market during the forecast period On the basis of region, the fluoroscopy equipment market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
In 2018, North America accounted for the largest share of the fluoroscopy equipment market.
The large share of North America can be attributed to the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341Leading Companies Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
The global fluoroscopy equipment market is projected to reach USD 7.1 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 4.4%.The major factors driving the growth of the fluoroscopy equipment are the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market in 2018.
The large share of this segment can be attributed to the increasing use of fluoroscopic imaging for diagnosis and interventional procedures and technological advancements in fixed C-arms.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341Surgical applications segment to grow at the highest CAGR in the fluoroscopy equipment market during the forecast periodOn the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.
The diagnostic applications market is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology), while the surgical applications market covers the market for C-arms in orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications.North America will continue to dominate the fluoroscopy equipment market during the forecast periodOn the basis of region, the fluoroscopy equipment market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
In 2018, North America accounted for the largest share of the fluoroscopy equipment market.
The large share of North America can be attributed to the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341Leading Companies Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
